Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Trial of Oral Melatonin in Elevated Blood Pressure [Phase 3]
Phase 3 trial exploring oral melatonin for elevated blood pressure; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Evaluation of an Antihypertensive Food Supplement Based on Aqueous Extract From Annona Muricata Sheets [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating an antihypertensive food supplement derived from Annona muricata aqueous extract; study completed.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Care Guides in the Primary Care Office (Phase II) [Phase 2]
Phase II clinical trial evaluating care guides in a primary care office setting for diabetes and hypertension, with additional mention of co…
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension [Phase 4]
Phase 4 trial updating on sequential nephron blockade versus dual blockade of the renin-angiotensin system with bisoprolol for resistant hyp…
-
FDA approval · 2019-04-04FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from NorthStar Rx LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-04FDA Approved: LOSARTAN POTASSIUM — Original Application (Hisun Pharmaceuticals USA, Inc.)
The FDA approved the Original Application for Losartan Potassium from Hisun Pharmaceuticals USA, enabling the marketing of a generic losarta…
-
FDA approval · 2019-04-02FDA Approved: TELMISARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Telmisartan from Aurobindo Pharma Limited.
-
FDA approval · 2019-04-02FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited, indicating an update to an already appro…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Amlodipine 10mg Drug Use Investigation
A completed clinical trial investigating the use of amlodipine 10 mg for hypertension; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function [NA]
Clinical trial comparing nebivolol and metoprolol effects on female sexual function in women with hypertension and female sexual dysfunction…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Counseling Older Adults to Control Hypertension [Phase 3]
Phase 3 clinical trial updates counseling strategies for older adults to control hypertension.
-
FDA approval · 2019-03-22FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for propranolol hydrochloride (generic propranolol HCl).
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension [Phase 4]
A Phase 4 clinical trial update evaluating the effect of nifedipine GITS in patients with mild-to-moderate primary hypertension.
-
FDA approval · 2019-03-22FDA Approved: ALISKIREN — Original Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s original ANDA for aliskiren, a generic renin inhibitor used to treat hypertension.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "
Clinical trial update for Azilsaltan Tablets (Azilva Tablets) in hypertension, with results posted.
-
FDA approval · 2019-03-15FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for a generic fixed-dose combination of valsartan and hydrochlorothiazide manufactured by Zydus Lifesciences …
-
FDA approval · 2019-03-12FDA Approved: VALSARTAN — Original Application (Ascend Laboratories, LLC)
FDA approved the original application for valsartan from Ascend Laboratories, making a generic ARB available. It covers indications includin…
-
FDA approval · 2019-03-12FDA Approved: NIFEDIPINE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approves Ingenus Pharmaceuticals' generic nifedipine under an Original Application (ANDA210614). The approved product is indicated for h…
-
FDA approval · 2019-03-08FDA Approved: ATENOLOL AND CHLORTHALIDONE — Original Application (Northstar Rx LLC.)
FDA approved Northstar Rx LLC's generic combination tablet of atenolol and chlorthalidone for hypertension under an original ANDA.
-
FDA approval · 2019-03-06FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for carvedilol (generic). The action confirms regulatory approval…
-
FDA approval · 2019-03-05FDA Approved: CLONIDINE — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved Ingenus Pharmaceuticals' original abbreviated new drug application for clonidine, authorizing a generic clonidine product.
-
FDA approval · 2019-03-04FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (AvKARE)
The FDA approved AvKARE's generic fixed-dose combination of telmisartan and hydrochlorothiazide for the treatment of hypertension.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008) [Phase 1]
Phase 1 trial evaluating safety, pharmacodynamics, and pharmacokinetics of various dosing regimens of MK-8266 in adults with hypertension; r…
-
FDA approval · 2019-02-26FDA Approved: CHLORTHALIDONE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original application for chlorthalidone, a generic diuretic. This enables marketing of the generic chlo…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Premature Ventricular Contractions (PVCs) and Blood Pressure Control [Phase 2]
Phase 2 trial evaluating management of Premature Ventricular Contractions and blood pressure control was terminated; results have been poste…